62 related articles for article (PubMed ID: 34306318)
1. Celecoxib and sulindac sulfide elicit anticancer effects on PIK3CA-mutated head and neck cancer cells through endoplasmic reticulum stress, reactive oxygen species, and mitochondrial dysfunction.
Thi Thanh Nguyen N; Yoon Lee S
Biochem Pharmacol; 2024 Jun; 224():116221. PubMed ID: 38641308
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial targeted β-lapachone induces mitochondrial dysfunction and catastrophic vacuolization in cancer cells.
Ma J; Lim C; Sacher JR; Van Houten B; Qian W; Wipf P
Bioorg Med Chem Lett; 2015 Nov; 25(21):4828-4833. PubMed ID: 26159482
[TBL] [Abstract][Full Text] [Related]
3. GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway.
Li YL; Chang JT; Lee LY; Fan KH; Lu YC; Li YC; Chiang CH; You GR; Chen HY; Cheng AJ
Oncotarget; 2017 Jan; 8(1):1508-1528. PubMed ID: 27903972
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional Regulation of GDF15 by EGR1 Promotes Head and Neck Cancer Progression through a Positive Feedback Loop.
Jin Y; Jung SN; Lim MA; Oh C; Piao Y; Kim HJ; Liu L; Kang YE; Chang JW; Won HR; Song K; Koo BS
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681812
[TBL] [Abstract][Full Text] [Related]
5. An omics approach to delineating the molecular mechanisms that underlie the biological effects of physical plasma.
Gonzales LISA; Qiao JW; Buffier AW; Rogers LJ; Suchowerska N; McKenzie DR; Kwan AH
Biophys Rev (Melville); 2023 Mar; 4(1):011312. PubMed ID: 38510160
[TBL] [Abstract][Full Text] [Related]
6. The Molecular Basis for Selectivity of the Cytotoxic Response of Lung Adenocarcinoma Cells to Cold Atmospheric Plasma.
Biryukov M; Semenov D; Kryachkova N; Polyakova A; Patrakova E; Troitskaya O; Milakhina E; Poletaeva J; Gugin P; Ryabchikova E; Zakrevsky D; Schweigert I; Koval O
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002354
[TBL] [Abstract][Full Text] [Related]
7. Plasma oncology: Adjuvant therapy for head and neck cancer using cold atmospheric plasma.
Li X; Rui X; Li D; Wang Y; Tan F
Front Oncol; 2022; 12():994172. PubMed ID: 36249012
[TBL] [Abstract][Full Text] [Related]
8. Open Questions in Cold Atmospheric Plasma Treatment in Head and Neck Cancer: A Systematic Review.
Perrotti V; Caponio VCA; Muzio LL; Choi EH; Di Marcantonio MC; Mazzone M; Kaushik NK; Mincione G
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142145
[TBL] [Abstract][Full Text] [Related]
9. Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
Kim EH; Jang H; Shin D; Baek SH; Roh JL
Apoptosis; 2016 Nov; 21(11):1265-1278. PubMed ID: 27544755
[TBL] [Abstract][Full Text] [Related]
10. Head and Neck Cancer Cell Death due to Mitochondrial Damage Induced by Reactive Oxygen Species from Nonthermal Plasma-Activated Media: Based on Transcriptomic Analysis.
Oh C; Won HR; Kang WS; Kim DW; Jung SN; Im MA; Liu L; Jin YL; Piao Y; Kim HJ; Kang YE; Lee MJ; Heo JY; Jun S; Sim NS; Lee JH; Song K; Kim YI; Chang JW; Koo BS
Oxid Med Cell Longev; 2021; 2021():9951712. PubMed ID: 34306318
[TBL] [Abstract][Full Text] [Related]
11. Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen species.
Kang SU; Cho JH; Chang JW; Shin YS; Kim KI; Park JK; Yang SS; Lee JS; Moon E; Lee K; Kim CH
Cell Death Dis; 2014 Feb; 5(2):e1056. PubMed ID: 24525732
[TBL] [Abstract][Full Text] [Related]
12. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
14. A Novel Polyphenol Conjugate Sensitizes Cisplatin-Resistant Head and Neck Cancer Cells to Cisplatin via Nrf2 Inhibition.
Kim EH; Jang H; Roh JL
Mol Cancer Ther; 2016 Nov; 15(11):2620-2629. PubMed ID: 27550943
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
